JPS6116941B2 - - Google Patents
Info
- Publication number
- JPS6116941B2 JPS6116941B2 JP13318480A JP13318480A JPS6116941B2 JP S6116941 B2 JPS6116941 B2 JP S6116941B2 JP 13318480 A JP13318480 A JP 13318480A JP 13318480 A JP13318480 A JP 13318480A JP S6116941 B2 JPS6116941 B2 JP S6116941B2
- Authority
- JP
- Japan
- Prior art keywords
- latex
- antibody
- antigen
- sensitized
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004816 latex Substances 0.000 claims description 89
- 229920000126 latex Polymers 0.000 claims description 89
- 239000003153 chemical reaction reagent Substances 0.000 claims description 37
- 210000002966 serum Anatomy 0.000 claims description 19
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 239000003505 polymerization initiator Substances 0.000 claims description 3
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- 239000000427 antigen Substances 0.000 description 30
- 102000036639 antigens Human genes 0.000 description 29
- 108091007433 antigens Proteins 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 20
- 239000002245 particle Substances 0.000 description 14
- 230000004520 agglutination Effects 0.000 description 12
- 239000008363 phosphate buffer Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 10
- 241000700199 Cavia porcellus Species 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000004220 aggregation Methods 0.000 description 8
- 230000002776 aggregation Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- 108010088751 Albumins Proteins 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000700198 Cavia Species 0.000 description 4
- 206010029719 Nonspecific reaction Diseases 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 4
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 230000000984 immunochemical effect Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 102000004641 Fetal Proteins Human genes 0.000 description 1
- 108010003471 Fetal Proteins Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000010556 emulsion polymerization method Methods 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- -1 oxides Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Polymerisation Methods In General (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13318480A JPS5757260A (en) | 1980-09-24 | 1980-09-24 | Manufacture of latex reagent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13318480A JPS5757260A (en) | 1980-09-24 | 1980-09-24 | Manufacture of latex reagent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5757260A JPS5757260A (en) | 1982-04-06 |
| JPS6116941B2 true JPS6116941B2 (enrdf_load_stackoverflow) | 1986-05-02 |
Family
ID=15098648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13318480A Granted JPS5757260A (en) | 1980-09-24 | 1980-09-24 | Manufacture of latex reagent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5757260A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0345439A (ja) * | 1989-07-13 | 1991-02-27 | Ichikoh Ind Ltd | 電動リモートコントロールミラーの駆動装置 |
| WO1994015216A1 (en) * | 1992-12-23 | 1994-07-07 | Niyazmatov Agzamdzhan Akhtamov | Process for obtaining a diagnostic reagent for detecting antigens and antibodies of infectious and other illnesses |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3455066B2 (ja) * | 1997-06-30 | 2003-10-06 | 花王株式会社 | Ｕｖ反射粉体及びそれを含有する化粧料 |
| DE69930193T2 (de) | 1998-12-14 | 2006-07-27 | Toray Industries, Inc. | Verfahren und Vorrichtung zur Herstellung von Kunststofffolien |
-
1980
- 1980-09-24 JP JP13318480A patent/JPS5757260A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0345439A (ja) * | 1989-07-13 | 1991-02-27 | Ichikoh Ind Ltd | 電動リモートコントロールミラーの駆動装置 |
| WO1994015216A1 (en) * | 1992-12-23 | 1994-07-07 | Niyazmatov Agzamdzhan Akhtamov | Process for obtaining a diagnostic reagent for detecting antigens and antibodies of infectious and other illnesses |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5757260A (en) | 1982-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4264766A (en) | Immunological diagnostic reagents | |
| EP0073611B1 (en) | Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays | |
| US4060597A (en) | Serological reagent and preparation thereof | |
| JPS63501902A (ja) | 梅毒の感作抗体試験 | |
| JPS6243138B2 (enrdf_load_stackoverflow) | ||
| EP0194156B1 (en) | Method of measuring the amount of immune antibody in serum | |
| JPS59224565A (ja) | 抗原検出用試薬 | |
| JPH0810224B2 (ja) | 生理活性物質固定化用ラテツクス及びこのラテツクスを用いるラテツクス試薬 | |
| JPH0616044B2 (ja) | 免疫学的ラテツクス凝集法 | |
| JPS6116941B2 (enrdf_load_stackoverflow) | ||
| JP2682697B2 (ja) | 免疫測定試薬および免疫測定法 | |
| JPS6116942B2 (enrdf_load_stackoverflow) | ||
| Quesada et al. | A simple kinetic model of antigen-antibody reactions in particle-enhanced light scattering immunoassays | |
| JPS6116944B2 (enrdf_load_stackoverflow) | ||
| JPS6352706B2 (enrdf_load_stackoverflow) | ||
| SE448032B (sv) | Alfa-l-antikropp och sett for framstellning derav, vilket motsvarande antigen er knutet till leversjukdomar | |
| JP2661664B2 (ja) | 抗ストレプトコッカスｄｎアーゼｂを検出するためのラテックス凝集法および凝集試薬 | |
| JPS5850646B2 (ja) | 血清学的診断試薬用ラテツクスの製造方法 | |
| JPS6116943B2 (enrdf_load_stackoverflow) | ||
| CA2088404C (en) | Method for the determination of antigens or antibodies in the presence of an immune complex | |
| JPS6352708B2 (enrdf_load_stackoverflow) | ||
| JPS6352707B2 (enrdf_load_stackoverflow) | ||
| JPH0145028B2 (enrdf_load_stackoverflow) | ||
| JPS6116940B2 (enrdf_load_stackoverflow) | ||
| JPH0810223B2 (ja) | 診断薬用ラテツクス、その製法および該ラテツクスを用いてなる診断薬 |